As COO of Nested Knowledge, Kathryn supports the development of software for living evidence reviews. Previously, Kathryn conducted health economics and outcomes research at Biohaven Pharmaceuticals as well as clinical addiction research at the National Institutes of Health.
Through the Young Adult Rare Representative (YARR), Kathryn advocates for rare disease policy change and speaks about the patient experience. Kathryn lives with a rare cardiac disease and Postural Orthostatic Tachycardia Syndrome (POTS). She has a Bachelor’s degree in Neuroscience from Wake Forest University.
